It is a trading private limited company based in Hyderabad, Telangana, India, established in 2011.
2011 | Hyderabad, Telangana, India | Struck OffSanare Pharmaceuticals Private Limited, a struck off private limited company, was established on 31 May 2011 in Hyderabad, Telangana, India. Engaging in wholesale within the trade sector, it holds CIN: U24232TG2011PTC074749. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Vijaya Bollu Lakshmi (Director), Chandrasekhararao Bollu (Director), Bollu Vamsi Krishna (Director). Past directors included Penumatsa Sarala Devi, Vijaya Bollu Lakshmi. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at Plot No.305, Road No.25 Jubilee Hills, Hyderabad, Telangana, 500033.
U24232TG2011PTC074749
074749
31 May 2011
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Sanare Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijaya Bollu Lakshmi | Director | 19 Jul 2014 | Current |
| Chandrasekhararao Bollu | Director | 20 Nov 2017 | Current |
| Bollu Vamsi Krishna | Director | 31 May 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Jul 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sanare Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 20.46% increase. The company also saw a substantial improvement in profitability, with a 67.12% increase in profit. The company's net worth Soared by an impressive increase of 44.83%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Sanare Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sanare Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sanare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanare Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sanare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was recorded as a recent event.
The activity Sanare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Hyderabad. was completed.
Chandrasekhararao Bollu was appointed as a Director was appointed as a Director on 20 Nov 2017 & has been associated with this company since 8 years 1 month . was recorded as a recent event.
Vijaya Bollu Lakshmi was appointed as a Director was appointed as a Director on 19 Jul 2014 & has been associated with this company since 11 years 5 months . was recorded as a recent event.
Bollu Vamsi Krishna was appointed as a Director was appointed as a Director on 31 May 2011 & has been associated with this company since 14 years 7 months . was recorded as a recent event.
Progress on Sanare Pharmaceuticals Private Limited was registered on 31 May 2011 with Roc Hyderabad & aged 14 years 7 months as per MCA records. was documented.
The CIN of Sanare Pharmaceuticals Private Limited is U24232TG2011PTC074749.
Sanare Pharmaceuticals Private Limited is headquartered at Plot No.305, Road No.25 Jubilee Hills, Hyderabad, Telangana, 500033.
Sanare Pharmaceuticals Private Limited was incorporated on 31 May 2011.
The current directors of Sanare Pharmaceuticals Private Limited are
The primary industry of Sanare Pharmaceuticals Private Limited is Trade.
Sanare Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sanare Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Sanare Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX